Ahmad G, Duffy J, Watson A J S
Cochrane Database Syst Rev. 2007 Apr 18(2):CD006106. doi: 10.1002/14651858.CD006106.pub2.
Hysterosalpingography (HSG) is a method of testing for tubal patency. Various pharmacological strategies are available that may reduce the pain during the procedure.
To compare the effectiveness of different types of pharmacological interventions for pain relief in women undergoing hysterosalpingography (HSG) for investigation of subfertility.
This review has drawn on the search strategy developed for the Menstrual Disorders and Subfertility Group. In addition MEDLINE and EMBASE were searched up to July 2006.
All randomised controlled trials investigating the pharmacological interventions for pain relief during HSG were investigated.
Data were extracted independently by the first two authors. Differences of opinion were registered and resolved by the third author. Results for each study were expressed as mean pain score and standard error of the mean with 95% confidence intervals.
The included eight trials reported on 570 women undergoing HSG.Overall, there was no evidence of benefit of using any analgesia compared with placebo for pain relief during the procedure (standard mean difference (SMD) of -0.05 (95%CI -0.25 to 0.14) or up to 29 minutes after HSG SMD 0.17, (95%CI -1.00 to 1.34)). Four RCTs involving 219 women found evidence of benefit with any analgesia in comparison to placebo for pain relief more than 30 minutes after HSG, with the SMD of -0.82(95%CI-1.18 to -0.45). One RCT involving 91 women compared the effectiveness of opioid analgesics versus non-opioid analgesics and reported no evidence of difference in pain relief at any stage of the procedure. One RCT involving 20 women compared the use of topical analgesia with a paracervical block, with analysis demonstrating more benefit to be gained from using topical analgesia during HSG, with the SMD of -2.03 (95%Cl-3.16 to -0.91).
AUTHORS' CONCLUSIONS: There is little evidence of benefit in terms of pain relief of any of the interventions considered in this study during or immediately after HSG. However, there is limited evidence of pain reduction 30 minutes after the procedure. Further RCTs should consider the role of non steroidal antiinflammatories (NSAIDs) and intrauterine anaesthetic during HSG.
子宫输卵管造影术(HSG)是一种检测输卵管通畅性的方法。有多种药理学策略可用于减轻该检查过程中的疼痛。
比较不同类型药理学干预措施对因不孕症接受子宫输卵管造影术(HSG)的女性缓解疼痛的效果。
本综述采用了为月经紊乱与不孕症小组制定的检索策略。此外,检索了截至2006年7月的MEDLINE和EMBASE数据库。
纳入所有研究子宫输卵管造影术(HSG)期间用于缓解疼痛的药理学干预措施的随机对照试验。
前两位作者独立提取数据。意见分歧由第三位作者记录并解决。每项研究的结果以平均疼痛评分和平均标准误表示,并给出95%置信区间。
纳入的8项试验报告了570例接受子宫输卵管造影术(HSG)的女性。总体而言,没有证据表明在检查过程中使用任何镇痛药与安慰剂相比能减轻疼痛(标准平均差(SMD)为-0.05(95%置信区间-0.25至0.14)),或在子宫输卵管造影术(HSG)后长达29分钟时减轻疼痛(标准平均差(SMD)为0.17,(95%置信区间-1.00至1.34))。4项涉及219名女性的随机对照试验发现,与安慰剂相比,在子宫输卵管造影术(HSG)后30分钟以上使用任何镇痛药有减轻疼痛的效果,标准平均差(SMD)为-0.82(95%置信区间-1.18至-0.45)。1项涉及91名女性的随机对照试验比较了阿片类镇痛药与非阿片类镇痛药的效果,报告在检查的任何阶段均无减轻疼痛差异的证据。1项涉及20名女性的随机对照试验比较了局部用药镇痛与宫颈旁阻滞的效果,分析表明在子宫输卵管造影术(HSG)期间使用局部用药镇痛更有益,标准平均差(SMD)为-2.03(95%置信区间-3.16至-0.91)。
在本研究中考虑的任何干预措施在子宫输卵管造影术(HSG)期间及术后即刻减轻疼痛方面几乎没有益处的证据。然而,术后30分钟有减轻疼痛的有限证据。进一步的随机对照试验应考虑非甾体抗炎药(NSAIDs)和子宫内麻醉剂在子宫输卵管造影术(HSG)中的作用。